/term/bs-unearned-income/STU:6A3A Autolus Therapeutics (STU:6A3A) Unearned Income
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (STU:6A3A) » Definitions » Unearned Income

Autolus Therapeutics (STU:6A3A) Unearned Income


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Unearned Income?

Unearned Income only applies to banks.


Autolus Therapeutics (STU:6A3A) Business Description

Traded in Other Exchanges
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.